Ad
related to: ciclosporin levels guidelines for children ppt powerpoint slides
Search results
Results from the WOW.Com Content Network
Ciclosporin, also spelled cyclosporine and cyclosporin, is a calcineurin inhibitor, used as an immunosuppressant medication. It is taken orally or intravenously for rheumatoid arthritis , psoriasis , Crohn's disease , nephrotic syndrome , eczema , and in organ transplants to prevent rejection .
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file
Ciclosporin is a cyclic polypeptide that has been used widely as an orally-available immunosuppressant. [1] It was originally used to prevent transplant rejection of solid organs but has also found use as an orally administered agent to treat psoriasis , [ 2 ] rheumatoid arthritis , [ 3 ] dry eye [ 4 ] and other auto-immune related conditions.
A biosafety level (BSL), or pathogen/protection level, is a set of biocontainment precautions required to isolate dangerous biological agents in an enclosed laboratory facility. The levels of containment range from the lowest biosafety level 1 (BSL-1) to the highest at level 4 (BSL-4).
Voclosporin, sold under the brand name Lupkynis, is a calcineurin inhibitor used as an immunosuppressant medication for the treatment of lupus nephritis. [2] [4] It is an analog of ciclosporin that has enhanced action against calcineurin and greater metabolic stability.
This is a good page, is there any objection to moving it to the INN ciclosporin and having cyclosporine redirect there? Let "ciclosporin" redirect to cyclosporine which is the compounds real name. Cacycle 21:13, 21 Dec 2004 (UTC) In accordance with Wikipedia:WikiProject_Drugs naming policy, I propose we move this page to the INN ciclosporin.
The GRADE approach separates recommendations following from an evaluation of the evidence as strong or weak. A recommendation to use, or not use an option (e.g. an intervention), should be based on the trade-offs between desirable consequences of following a recommendation on the one hand, and undesirable consequences on the other.
The child-resistant locking closure for containers was invented in 1967 by Dr. Henri Breault. [7]A history of accidents involving children opening household packaging and ingesting the contents led the United States Congress to pass the Poison Prevention Packaging Act of 1970, authored by U.S. Senator Frank E. Moss of Utah.
Ad
related to: ciclosporin levels guidelines for children ppt powerpoint slides